Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587600 · ClinicalTrials.gov registry record · Phase 2
Biomarkers in Phototherapy of Barrett's Esophagus
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 208
- Enrollment target
NCT00587600: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00587600 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587600, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 208 participants
- Enrollment target
Study Summary
This study is being done to find out if Photodynamic Therapy (treatment with a red light and a drug called photofrin) or Radiofrequency ablation works the same for patients who have biomarkers (abnormalities in molecules of cells that may or may not help predict cancer) present in their Barrett's esophagus as for patients who do not have biomarkers.
Interventions
- PROCEDURE Photodynamic therapy
- PROCEDURE radiofrequency ablation of barrett's esophagus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2002-12 |
| Est. Completion | 2017-04-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587600
The ClinicalTrials.gov registry entry for NCT00587600 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photodynamic therapy is the first listed.
NCT00587600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587600 about?
NCT00587600 is a clinical study titled "Biomarkers in Phototherapy of Barrett's Esophagus". This study is being done to find out if Photodynamic Therapy (treatment with a red light and a drug called photofrin) or Radiofrequency ablation works the same for patients who have biomarkers (abnormalities in molecules of cells that may or may not help predict cancer) present in their Barrett's es...
What is the current status of trial NCT00587600?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 208 participants. The study started on 2002-12. Estimated completion is 2017-04-21.
What interventions are being tested in trial NCT00587600?
The interventions under investigation include: Photodynamic therapy (PROCEDURE), radiofrequency ablation of barrett's esophagus (PROCEDURE).
Who is sponsoring clinical trial NCT00587600?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.